HIV-associated dementia

RESEARCH STUDY

We are currently recruiting healthy men aged 45 years and over for a study investigating the link between HIV infection and dementia.

In conjunction with St Vincent’s Hospital, the University of New South Wales and Neuroscience Research Australia (NeuRA), the study aims to estimate the prevalence of memory and concentration difficulties in older individuals with long-term HIV infection, as well as the means (if any) by which long-term HIV infection contributes to the incidence of an illness like dementia.

An important part of this study is recruiting healthy control participants as a comparison group. To participate, you must be:

  • male
  • 45 years old or older
  • in good health, with no psychiatric or neurological disoders

We will ask you to make two visits to St Vincent’s Hospital in Sydney over an 18 month period. Each visit will last two hours, during which we will ask you to participate in a neuropsychological test of attention, memory, visuo-spatial and language function. We will also ask to take an MRI scan of your head (this involves lying quietly in the MRI scanner for 45 minutes).

If you so chose, we can make the study results available to your doctor of choice. We will reimburse your travel/parking expenses.

To participate, or for more information contact Dr Lucette Cysique on 0431 576 710 or via email: lcysique@unsw.edu.au

 

See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

LEAD!- Leveraging Evidence into Action on Dementia

Currently, there is no effective treatment for dementia, highlighting the urgent need to preventing more cases through evidence-based strategies for risk reduction. As there is an overlap between the risk factors for dementia and other preventable non-communicable diseases including stroke, diabetes, and heart disease, it is important to build upon proven risk-reduction strategies. What is LEAD? LEAD! is a project funded by the NHMRC Boosting Dementia Research Grant led by Professor Kaarin Anstey. It involves an international collaboration between leading academics, clinicians, consumers, and community members. Organisations involved include the Department of Health, WHO, Dementia Australia, Alzheimer’s Disease International, Diabetes Australia, and Heart Foundation. The project aims to translate dementia research and implement evidence-based strategies for dementia risk reduction to individuals, communities, and healthcare centres. Three workstreams The project has three concurrent workstreams over five years: Development, Implementation, and Evaluation and adoption. The Development stream, led by Professor Kaarin Anstey and Associate Professor Peters, focuses on building a new tool for predicting dementia and other non-communicable diseases including stroke, diabetes or myocardial infarction. The tool will be available to the public, researchers and clinicians. It will save clinical assessment time, accurately predict multiple outcomes and will be more acceptable in comparison to using individual tools for each disease outcome. The Implementation stream led by Professor Nicola Lautenschalger’s team at the University of Melbourne, will develop strategies to support the implementation of dementia risk reduction evidence by engaging with consumers, clinicians, policy makers, and the public. The stream will develop strategies for incorporating the new risk assessment tool into various technological platforms (e.g., websites or apps). The Evaluation and adoption stream, led by Professor Anstey and in collaboration with Professor Louisa Jorm and Dr Heidi Welberry at UNSW, focuses on measuring trajectories of Australian’s national risk factor profiles for multiple chronic diseases. Collaboration with key stakeholders including the WHO will help build an evaluation framework and methodology for implementing evidence on dementia risk reduction based on WHO guidelines at national level and in the global context.
PROJECT